Primary extremity soft tissue sarcomas: Outcome improvement over time at a single institution

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: To assess changes in survival over time of extremity soft tissue sarcoma (ESTS) patients treated at a single reference institution. Patients and methods: Patients with primary localized adult-type ESTS surgically treated at our institution between 1987 and 2007 were retrospectively reviewed. Patients were categorized into four 5-year groups according to the timing of their first operation. Crude cumulative incidence (CCI) of sarcoma-specific mortality (SSM), local recurrence (LR), and distant metastases (DMs) were calculated for each time period. Results: A total of 1094 patients were identified. Median follow-up was 81 months. CCI of SSM and LR were significantly better in period 4 in comparison to periods 1-3 (P <0.001 for both end points), dropping, respectively, from 15% to 6% and from 23% to 9%. An overall improvement of DMs-free survival at 5 years could be detected in the latter period, as well as a better postmetastasis survival. Conclusions: Reference institutions for sarcomas may have improved their outcome in the last years. Although biases of retrospective analyses as well as the effect of institutional learning curves need to be discounted, it is possible that optimal exploitation of a series of subtle improvements in sarcoma treatment may make a difference in results currently achievable.

Original languageEnglish
Pages (from-to)1675-1681
Number of pages7
JournalAnnals of Oncology
Volume22
Issue number7
DOIs
Publication statusPublished - 2011

Fingerprint

Sarcoma
Extremities
Survival
Neoplasm Metastasis
Recurrence
Learning Curve
Mortality
Incidence

Keywords

  • Chemotherapy
  • Prognosis
  • Radiotherapy
  • Sarcoma
  • Surgery
  • Treatment outcome

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

@article{ccc7b3e33db84d4c83571bed6b33e51a,
title = "Primary extremity soft tissue sarcomas: Outcome improvement over time at a single institution",
abstract = "Background: To assess changes in survival over time of extremity soft tissue sarcoma (ESTS) patients treated at a single reference institution. Patients and methods: Patients with primary localized adult-type ESTS surgically treated at our institution between 1987 and 2007 were retrospectively reviewed. Patients were categorized into four 5-year groups according to the timing of their first operation. Crude cumulative incidence (CCI) of sarcoma-specific mortality (SSM), local recurrence (LR), and distant metastases (DMs) were calculated for each time period. Results: A total of 1094 patients were identified. Median follow-up was 81 months. CCI of SSM and LR were significantly better in period 4 in comparison to periods 1-3 (P <0.001 for both end points), dropping, respectively, from 15{\%} to 6{\%} and from 23{\%} to 9{\%}. An overall improvement of DMs-free survival at 5 years could be detected in the latter period, as well as a better postmetastasis survival. Conclusions: Reference institutions for sarcomas may have improved their outcome in the last years. Although biases of retrospective analyses as well as the effect of institutional learning curves need to be discounted, it is possible that optimal exploitation of a series of subtle improvements in sarcoma treatment may make a difference in results currently achievable.",
keywords = "Chemotherapy, Prognosis, Radiotherapy, Sarcoma, Surgery, Treatment outcome",
author = "A. Gronchi and R. Miceli and C. Colombo and P. Collini and S. Stacchiotti and P. Olmi and L. Mariani and R. Bertulli and M. Fiore and Casali, {P. G.}",
year = "2011",
doi = "10.1093/annonc/mdq643",
language = "English",
volume = "22",
pages = "1675--1681",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "7",

}

TY - JOUR

T1 - Primary extremity soft tissue sarcomas

T2 - Outcome improvement over time at a single institution

AU - Gronchi, A.

AU - Miceli, R.

AU - Colombo, C.

AU - Collini, P.

AU - Stacchiotti, S.

AU - Olmi, P.

AU - Mariani, L.

AU - Bertulli, R.

AU - Fiore, M.

AU - Casali, P. G.

PY - 2011

Y1 - 2011

N2 - Background: To assess changes in survival over time of extremity soft tissue sarcoma (ESTS) patients treated at a single reference institution. Patients and methods: Patients with primary localized adult-type ESTS surgically treated at our institution between 1987 and 2007 were retrospectively reviewed. Patients were categorized into four 5-year groups according to the timing of their first operation. Crude cumulative incidence (CCI) of sarcoma-specific mortality (SSM), local recurrence (LR), and distant metastases (DMs) were calculated for each time period. Results: A total of 1094 patients were identified. Median follow-up was 81 months. CCI of SSM and LR were significantly better in period 4 in comparison to periods 1-3 (P <0.001 for both end points), dropping, respectively, from 15% to 6% and from 23% to 9%. An overall improvement of DMs-free survival at 5 years could be detected in the latter period, as well as a better postmetastasis survival. Conclusions: Reference institutions for sarcomas may have improved their outcome in the last years. Although biases of retrospective analyses as well as the effect of institutional learning curves need to be discounted, it is possible that optimal exploitation of a series of subtle improvements in sarcoma treatment may make a difference in results currently achievable.

AB - Background: To assess changes in survival over time of extremity soft tissue sarcoma (ESTS) patients treated at a single reference institution. Patients and methods: Patients with primary localized adult-type ESTS surgically treated at our institution between 1987 and 2007 were retrospectively reviewed. Patients were categorized into four 5-year groups according to the timing of their first operation. Crude cumulative incidence (CCI) of sarcoma-specific mortality (SSM), local recurrence (LR), and distant metastases (DMs) were calculated for each time period. Results: A total of 1094 patients were identified. Median follow-up was 81 months. CCI of SSM and LR were significantly better in period 4 in comparison to periods 1-3 (P <0.001 for both end points), dropping, respectively, from 15% to 6% and from 23% to 9%. An overall improvement of DMs-free survival at 5 years could be detected in the latter period, as well as a better postmetastasis survival. Conclusions: Reference institutions for sarcomas may have improved their outcome in the last years. Although biases of retrospective analyses as well as the effect of institutional learning curves need to be discounted, it is possible that optimal exploitation of a series of subtle improvements in sarcoma treatment may make a difference in results currently achievable.

KW - Chemotherapy

KW - Prognosis

KW - Radiotherapy

KW - Sarcoma

KW - Surgery

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=79959746009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959746009&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdq643

DO - 10.1093/annonc/mdq643

M3 - Article

C2 - 21242585

AN - SCOPUS:79959746009

VL - 22

SP - 1675

EP - 1681

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 7

ER -